Rentabilitas dodolan miturut bathi resik Genetic Technologies Limited (GENE)

GENE (gtglabs.com) - tandha merek perusahaan

Genetic Technologies generates revenue streams through its unique GeneType tests, which enable the preemptive detection of diabetes and cancer. The net profit margin confirms the profitability trend, where -156.80 represents the latest metric reading. The company is scaling B2B sales via the insurance sector, aiming to integrate polygenic risk scores into personalized medicine standards for the early detection of pathologies.

gtglabs.com (GENE) - Margin dodolan perusahaan saka 04.07.2022 nganti 26.10.2024

Genetic Technologies Ltd (GENE) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
- rincian kapitalisasi pasar:
Pambiji fundamental perusahaan:Genetic Technologies Ltd - GENE
Produk dadi Genetic Technologies Limited

Sales margin reflects the share of net profit in total revenue, measuring the efficiency of converting income into final capital. Investors utilize this metric to assess business resilience against operating expenses and inflationary shocks. By analyzing the final sales margin, one can observe the dependence of Genetic Technologies (GENE) profitability on service scaling. Current profit volatility is directly linked to the process of integrating genetic tests into US and Australian medical protocols. Growth in this indicator would confirm the commercial viability of the company's model.

Analisis perusahaan pesaing

A (Agilent Technologies) - Rentabilitas dodolan miturut bathi resik|DGX: Rentabilitas resik perusahaan|Margin resik Illumina Platform|EXAS (Exact Sciences) - Rentabilitas resik perusahaan|Rentabilitas dodolan miturut bathi resik RVTY (PerkinElmer)|Bio-Rad - Rentabilitas dodolan resik|Margin dodolan resik NNNN (Anbio)|Tingkat bathi resik SHC|QDEL - Margin resik|OPK: Margin resik|caredx.com (CDNA) - Margin resik|MRVI (Maravai LifeSciences) - Margin resik|FLGT (Fulgent) - Margin dodolan resik|Standard BioTools Inc (LAB) - Margin dodolan perusahaan|Margin dodolan resik CTKB|Rentabilitas dodolan miturut bathi resik OraSure Technologies Inc OSUR|Margin dodolan resik XGN (Exagen Diagnostics)|Margin dodolan resik mdxhealth.com MDXH|LUCD - Margin resik|PRE: Margin resik|IMDX (Insight Molecular Diagnostics Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan miturut bathi resik Trinity Biotech PLC|PRPH (prophaselabs.com) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Ainos, Inc. (AIMD)|Margin dodolan resik CODX|HSCS (HeartSciences) - Tingkat bathi resik|Margin resik Biomerica, Inc BMRA|CDIO - Rentabilitas dodolan miturut bathi resik|ONCO - Margin resik|VRAX - Margin dodolan resik|Bluejay Diagnostics Inc (BJDX) - Margin resik|Aspira Women's Health Inc. - Tingkat bathi resik|AXDX (Accelerate Diagnostics Inc) - Margin dodolan resik|Margin resik Centogene N.V. CNTG|Margin dodolan resik ENZ|Margin resik FRES (Fresh2)|Margin dodolan resik ME (23andme.com)|Psychemedics Corp. (PMD) - Margin resik